Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Edward Mayerson"'
Autor:
Howard Streicher, Elad Sharon, Razelle Kurzrock, Young Kwang Chae, Megan Othus, Edward Mayerson, Melissa Plets, Charles Blanke, Ashish Sangal, Benjamin Powers, Chung-Tsen Hsueh, Rashmi Chugh, Suresh Nair, Mark Agulnik, G Thomas Budd, Michael J Wagner, Sandip P Patel, Chris Ryan, Adrienne I Victor, Kirsten M Leu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 8 (2021)
Purpose Angiosarcoma is a rare aggressive endothelial cell cancer with high mortality. Isolated reports suggest immune checkpoint inhibition efficacy in angiosarcoma, but no prospective studies have been published. We report results for angiosarcoma
Externí odkaz:
https://doaj.org/article/ad13fb519e1d42b98dad31e0b713b156
Autor:
Michael Wagner, Howard Streicher, Elad Sharon, Razelle Kurzrock, Young Kwang Chae, Megan Othus, Sandip Patel, Edward Mayerson, Christopher Ryan, Melissa Plets, Charles Blanke, Ashish Sangal, Benjamin Powers, George Budd, Adrienne Victor, Chung-Tsen Hsueh, Rashmi Chugh, Suresh Nair, Kirsten Leu, Mark Agulnik
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/5f959daaad1747298fd9676eb4ec2d8a
Autor:
Elad Sharon, Razelle Kurzrock, Young Kwang Chae, Megan Othus, Sandip Patel, Sarah Fenton, Cristina Rodriguez, Adedayo Onitilo, Ahmad Mattour, Igor Rybkin, Jourdain Hayward, Christine McLeod, Helen Chen, Edward Mayerson, Christopher Ryan, Melissa Plets, Charles Blanke
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/1558de3140ee43879f8958d774807358
Autor:
Primo N. Lara Jr, Edward Mayerson, Erik Gertz, Catherine Tangen, Amir Goldkorn, Marta van Loan, Maha Hussain, Shilpa Gupta, Jingsong Zhang, Mamta Parikh, Przemyslaw Twardowski, David I. Quinn, Michael LeBlanc, Nicholas J. Vogelzang, Ian Thompson, Neeraj Agarwal
Publikováno v:
European Urology.
Autor:
Razelle Kurzrock, Charles D. Blanke, Melissa Plets, Christopher W. Ryan, Edward Mayerson, Elad Sharon, Helen X. Chen, Christine McLeod, Jourdain Hayward, W. Michael Korn, Zoran Gatalica, Marc Matrana, Tareq Al Baghdadi, Anup Kasi, Manisha H. Shah, Annette Fontaine, Preet Paul Singh, Donna E. Hansel, Francis J. Giles, Young Kwang Chae, Megan Othus, Sandip P. Patel
Purpose:Immune checkpoint blockade has improved outcomes across tumor types; little is known about the efficacy of these agents in rare tumors. We report the results of the (nonpancreatic) neuroendocrine neoplasm cohort of SWOG S1609 dual anti–CTLA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1e764ebbb5f97894227c92dd11d1eff
https://doi.org/10.1158/1078-0432.c.6528908
https://doi.org/10.1158/1078-0432.c.6528908
Autor:
Razelle Kurzrock, Young Kwang Chae, Charles D. Blanke, Melissa Plets, Edward Mayerson, Robert J. Gray, Larissa A. Korde, Elad Sharon, Roisin M. Connolly, David D. Biggs, Jane M. Raymond, Olwen Hahn, Frank J. Brescia, Jordi Rodon Ahnert, Hamid R. Mirshahidi, Anne P. O'Dea, Collin T. Zimmerman, Scott A. Anderson, Mridula P. Reddy, Anna Maria V. Storniolo, Barbara J. Haley, Mary D. Chamberlin, Scott M. Schuetze, Rashmi Chugh, Kathy D. Miller, Sandip Pravin Patel, Megan Othus, Sylvia Adams
Supplemental Figure 1: CONSORT Diagram
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c80dc6dec04f0090392e953ac68f745a
https://doi.org/10.1158/1078-0432.22482155
https://doi.org/10.1158/1078-0432.22482155
Autor:
Razelle Kurzrock, Charles D. Blanke, Melissa Plets, Christopher W. Ryan, Edward Mayerson, Elad Sharon, Helen X. Chen, Christine McLeod, Jourdain Hayward, W. Michael Korn, Zoran Gatalica, Marc Matrana, Tareq Al Baghdadi, Anup Kasi, Manisha H. Shah, Annette Fontaine, Preet Paul Singh, Donna E. Hansel, Francis J. Giles, Young Kwang Chae, Megan Othus, Sandip P. Patel
Appendix
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c8e67fd9cfcbfbc976dd7fde7eda278
https://doi.org/10.1158/1078-0432.22474763
https://doi.org/10.1158/1078-0432.22474763
Autor:
Razelle Kurzrock, Young Kwang Chae, Charles D. Blanke, Melissa Plets, Edward Mayerson, Robert J. Gray, Larissa A. Korde, Elad Sharon, Roisin M. Connolly, David D. Biggs, Jane M. Raymond, Olwen Hahn, Frank J. Brescia, Jordi Rodon Ahnert, Hamid R. Mirshahidi, Anne P. O'Dea, Collin T. Zimmerman, Scott A. Anderson, Mridula P. Reddy, Anna Maria V. Storniolo, Barbara J. Haley, Mary D. Chamberlin, Scott M. Schuetze, Rashmi Chugh, Kathy D. Miller, Sandip Pravin Patel, Megan Othus, Sylvia Adams
Supplemental Table 1: Clinical and tumor characteristics of long-term responders
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c8f19b8c5f1834ac753320355cffb3b
https://doi.org/10.1158/1078-0432.22482149
https://doi.org/10.1158/1078-0432.22482149
Autor:
Razelle Kurzrock, Young Kwang Chae, Charles D. Blanke, Melissa Plets, Edward Mayerson, Robert J. Gray, Larissa A. Korde, Elad Sharon, Roisin M. Connolly, David D. Biggs, Jane M. Raymond, Olwen Hahn, Frank J. Brescia, Jordi Rodon Ahnert, Hamid R. Mirshahidi, Anne P. O'Dea, Collin T. Zimmerman, Scott A. Anderson, Mridula P. Reddy, Anna Maria V. Storniolo, Barbara J. Haley, Mary D. Chamberlin, Scott M. Schuetze, Rashmi Chugh, Kathy D. Miller, Sandip Pravin Patel, Megan Othus, Sylvia Adams
Purpose:Metaplastic breast cancer (MpBC) is a rare aggressive subtype that responds poorly to cytotoxics. Median survival is approximately 8 months for metastatic disease. We report results for advanced MpBC treated with ipilimumab + nivolumab, a coh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba52afc8d9f818247af6b698da8bd432
https://doi.org/10.1158/1078-0432.c.6530837
https://doi.org/10.1158/1078-0432.c.6530837
Autor:
Annette Fontaine, Anup Kasi, Jourdain Hayward, Tareq Al Baghdadi, Manisha Shah, Melissa Plets, Megan Othus, Razelle Kurzrock, Edward Mayerson, Zoran Gatalica, Francis J. Giles, Christopher W. Ryan, Donna E. Hansel, Christine M. McLeod, Sandip Pravin Patel, Elad Sharon, Helen X. Chen, Marc Matrana, W. Michael Korn, Preet Paul Singh, Young Kwang Chae, Charles D. Blanke
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 26, iss 10
Clin Cancer Res
Clin Cancer Res
Purpose: Immune checkpoint blockade has improved outcomes across tumor types; little is known about the efficacy of these agents in rare tumors. We report the results of the (nonpancreatic) neuroendocrine neoplasm cohort of SWOG S1609 dual anti–CTL